申请人:Thormann Michael
公开号:US20090269301A1
公开(公告)日:2009-10-29
The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy,
R
1
represents heteroaryl, -carbocyclyl-heteroaryl, -alkenylheteroaryl or -alkylheteroaryl;
R
2
represents hydrogen; halogen; alkenyl; alkynyl; -alkenylaryl; -alkenylheteroaryl; alkyl, which may optionally be substituted by one or more groups selected from halogen, hydroxyl, alkoxy-, -thioalkyl, —C(O)OH and —C(O)O-alkyl; carbocyclyl, which may optionally be substituted by one or more groups selected from alkyl, halogen, hydroxyl, alkoxy-, -thioalkyl, —C(O)OH and —C(O)O-alkyl; -alkylcarbocyclyl; -alkylheterocyclyl; aryl; heteroaryl; heterocyclyl; -alkylaryl; -alkyl(aryl)
2
, -alkylheteroaryl; -aryl-heteroaryl; -heterocyclyl-aryl; -aryl-aryl; -heteroaryl-aryl; -heteroaryl-heteroaryl, and —C(O)R
4
;
R
3
represents halogen; alkyl optionally substituted by one or more groups selected from halogen, hydroxyl, alkoxy, thioalkyl, —C(O)OH and —C(O)O-alkyl; aryl; heteroaryl; —C(O)R
5
;
R
4
and R
5
independently represent alkyl, aryl, heteroaryl, -alkylaryl, -alkylheteroaryl, carbocyclyl, heterocyclyl, -alkylcarbocyclyl and -alkylheterocyclyl,
with the proviso that, when R
1
is imidazolyl, -carbocyclyl-imidazolyl, -alkenyl-imidazolyl or -alkyl-imidazolyl, then R
3
may not be —C(O)R
5
.
本发明涉及式(I)化合物,其组合物和用于疾病治疗的用途。其中,R1代表杂环芳基,-碳环芳基-杂环芳基,-烯基杂环芳基或-烷基杂环芳基;R2代表氢,卤素,烯基,炔基,-烯基芳基,-烯基杂环芳基,烷基,可以选择被一个或多个从卤素,羟基,烷氧基,硫代烷基,-C(O)OH和-C(O)O-烷基中选择的基团取代的烷基,可以选择被一个或多个从烷基,卤素,羟基,烷氧基,硫代烷基,-C(O)OH和-C(O)O-烷基中选择的基团取代的碳环芳基,可以选择被一个或多个从烷基,卤素,羟基,烷氧基,硫代烷基,-C(O)OH和-C(O)O-烷基中选择的基团取代的-烷基碳环芳基,-烷基杂环芳基,芳基,杂环芳基,杂环芳基,-烷基芳基2,-烷基杂环芳基,-芳基杂环芳基,-杂环芳基-芳基,-芳基-芳基,-杂环芳基-芳基,-杂环芳基-杂环芳基和-C(O)R4;R3代表卤素,烷基,可以选择被一个或多个从卤素,羟基,烷氧基,硫代烷基,-C(O)OH和-C(O)O-烷基中选择的基团取代的烷基,芳基,杂环芳基和-C(O)R5;R4和R5独立地代表烷基,芳基,杂环芳基,-烷基芳基,-烷基杂环芳基,碳环芳基,杂环芳基,-烷基碳环芳基和-烷基杂环芳基,但当R1是咪唑基,-碳环芳基-咪唑基,-烯基咪唑基或-烷基咪唑基时,R3不能是-C(O)R5。